Add to Cart View Cart/Checkout More Products

Volume 9, 2005 CD

Six back issues of The International Journal of Pharmaceutical Compounding from 2005 on one convenient CD.
Only $95 per CD.
(Multiple Theme or Library CD orders priced at: 2 to 5 = $85; 6 to 9 = $75; 10 or more = $65 each.)

  • Permanant storage and easy retrieval of IJPC articles, formulations, SOP's and more.
  • Print IJPC articles in color for your marketing needs.

The back issues are stored as a high-resolution, full-color Adobe Portable Document Format (.pdf) file, complete with an electronic Table of Contents.

They may be searched by keyword and printed by the page. Software to read the PDF file is freely available from the Adobe Reader page.

Issues
Volume/IssueDateTitle
Vol. 9 No. 1 January/February 2005 Sterile Preparations
Vol. 9 No. 2 March/April 2005 Health and Wellness
Vol. 9 No. 3 May/June 2005 Veterinary Compounding
Vol. 9 No. 4 July/August 2005 Human Hormone Replacement Therapy
Vol. 9 No. 5 September/October 2005 Pain Management
Vol. 9 No. 6 November/December 2005 Pediatrics

Articles
Volume/IssuePageTitle
Vol. 9 No. 1 2 PreScription: CompoundingToday.com and Sources of Compounding Chemicals
Vol. 9 No. 1 5 Book Review: The Medical & Surgical Practice of NaProTECHNOLOGY
Vol. 9 No. 1 5 Literature Reviews
Vol. 9 No. 1 11 USP Chapter <797>: Practical Solutions for Microbiology, Sterility, and Pyrogen Testing
Vol. 9 No. 1 15 Using ACDs in the Practice of Pharmacy
Vol. 9 No. 1 23 USP Chapter <797> and Preparing for a JCAHO Survey
Vol. 9 No. 1 29 Questions and Answers: USP Chapter <797> and JCAHO Compliance
Vol. 9 No. 1 33 A Dialogue Concerning Contamination Control Systems: Where Does the Isolator Fit In?
Vol. 9 No. 1 37 The Marketing Equation Your Ad Man Doesn't Want You to Know: How to Double Your Bottom Line without Spending an Extra Dime
Vol. 9 No. 1 42 Defining Success
Vol. 9 No. 1 44 The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List")
Vol. 9 No. 1 47 Quality-Control Analytical Methods: Microbial Testing Aspects of USP <797> for Compounded Sterile Preparations
Vol. 9 No. 1 50 Wish You Were Here: Pharmacy Museum, Weimar, Texas
Vol. 9 No. 1 53 Barrier Isolators, Isolators, and Glove Boxes--What's the Difference?
Vol. 9 No. 1 57 Calculations
Vol. 9 No. 1 58 Basics of Compounding with Acids
Vol. 9 No. 1 61 Standard Operating Procedure: Compounding with Concentrated Acids
Vol. 9 No. 1 62 Amitriptyline Hydrochloride 10-mg/mL Injection
Vol. 9 No. 1 63 Fentanyl 15-mg/mL Injection, Preservative Free
Vol. 9 No. 1 64 Gabapentin 2-mg/mL Injection, Preservative Free
Vol. 9 No. 1 65 Guaifenesin 50-mg/mL Injection
Vol. 9 No. 1 66 Lidocaine Hydrochloride-2%, Ketolorac Tromethamine-3%, and Clonidine Hydrochloride-0.1% Injection
Vol. 9 No. 1 67 Naltrexone Hydrochloride 1.4-mg/mL Injection, Preservative Free
Vol. 9 No. 1 68 Naproxen Sodium 100-mg/mL Injection
Vol. 9 No. 1 69 Phenol 8% Injection
Vol. 9 No. 1 70 Tolazoline Hydrochloride 25-mg/mL Injection
Vol. 9 No. 1 71 Tramadol Hydrochloride 50-mg/mL Injection, Preservative Free
Vol. 9 No. 1 72 Chemical Stability of Metoclopramide Hydrochloride Injection Diluted with 0.9% Sodium Chloride Injection in Polypropylene Syringes at Room Temperature
Vol. 9 No. 1 75 Physical characteristics of selected over-the-counter medications
Vol. 9 No. 1 82 Stability of an Extemporaneously Compounded Propylthiouracil Suspension
Vol. 9 No. 1 87 Scientific and Professional Reviewers for 2004
Vol. 9 No. 1 88 PostScription: Pharmacy, Pharmacists, and Pharmacy Practice
Vol. 9 No. 2 90 Prescription: Too Much Information?
Vol. 9 No. 2 93 Book Review: Bacteria for Breakfast: Probiotics for Good Health
Vol. 9 No. 2 93 Book Review: Miracle Cure: How to Solve America's Health Care Crisis and Why Canada Isn't the Answer
Vol. 9 No. 2 94 Literature Reviews
Vol. 9 No. 2 99 N-acetylcysteine Used to Decrease the Incidence of Contrast-Induced Nephropathy Following Radiographic Procedures: A Literature Review
Vol. 9 No. 2 105 Treatment of Mercury Intoxication With Dimercaptopropanesulfonate
Vol. 9 No. 2 111 What a Pharmacist Needs to Know about Bariatric Surgery: Compounding Opportunities
Vol. 9 No. 2 117 Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure
Vol. 9 No. 2 120 Use of Domperidone as a Prokinetic and Antiemetic
Vol. 9 No. 2 127 Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Vol. 9 No. 2 133 Communication Makes It or Breaks It
Vol. 9 No. 2 136 Quality-Control Analytical Methods: Chemical Testing Aspects of USP <797> for Compounded Sterile Preparations
Vol. 9 No. 2 140 Basics of Compounding for Hair Care--Part I: Medicated Shampoos
Vol. 9 No. 2 145 Standard Operating Procedure: SOP Master Book--Maintenance
Vol. 9 No. 2 146 Calculations
Vol. 9 No. 2 147 Aspirin 30-mg/mL Desensitization Oral Liquid, Nonaqueous
Vol. 9 No. 2 148 Capsaicin 0.2-mg Troches
Vol. 9 No. 2 149 Clobetasol Topical Spray
Vol. 9 No. 2 150 Clobetasol and Dyclonine Oral Paste
Vol. 9 No. 2 151 Homatropine 3-mg Rapid Dissolving Tablets
Vol. 9 No. 2 152 Isosorbide Dinitrate 0.1% Topical Spray
Vol. 9 No. 2 153 Sildenafil 1% Vaginal Cream or Gel
Vol. 9 No. 2 154 Sildenafil Vaginal Suppository
Vol. 9 No. 2 155 Silver Sulfadiazine 1% and Fluriprofen 2% Cream
Vol. 9 No. 2 156 Thiabendazole 15% Cream
Vol. 9 No. 2 157 In Vitro Evaluation of Extemporaneously Compounded Slow-Release Capsules Containing Morphine Sulfate or Oxycodone Hydrochloride
Vol. 9 No. 2 165 Chemical Stability of Isoniazid in an Oral Liquid Dosage Form
Vol. 9 No. 2 167 PostScription: Experts Everywhere
Vol. 9 No. 3 170 PreScription: Working Together: Lessons from a Rope
Vol. 9 No. 3 173 Book Reviews: Veterinary Drug Handbook: Client Information Edition
Vol. 9 No. 3 173 Book Reviews: When Change Is Your Company's Middle Name: The Professional's Guide to Understanding the Human Side of Business Transformation
Vol. 9 No. 3 174 Literature Reviews
Vol. 9 No. 3 178 Update on Transdermals for Animal Patients
Vol. 9 No. 3 185 Compounding for Behavior Problems in Animals
Vol. 9 No. 3 195 Compounding Antiangiogenic Cancer Therapy for Animals
Vol. 9 No. 3 201 Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs
Vol. 9 No. 3 207 Quality-Control Analytical Methods: Determination of Tapped Bulk Volume for Compounded Prescriptions
Vol. 9 No. 3 209 Survey of State Veterinary Compounding Laws and Regulations
Vol. 9 No. 3 213 What Customers Want
Vol. 9 No. 3 215 Basics of Compounding for Hair Care -- Part 2: Medicated Conditions
Vol. 9 No. 3 220 Pharmacy History: Pharmacy Knots
Vol. 9 No. 3 222 Standard Operating Procedure: Exhaust System Airflow Monitoring (Individual Capsule Stations)
Vol. 9 No. 3 224 Calculations
Vol. 9 No. 3 225 Calcitriol 100 ng/mL Oral Liquid, Veterinary
Vol. 9 No. 3 226 Dexamethasone Oral Powder 10-mg Units, Veterinary
Vol. 9 No. 3 227 Dipyrone 500-mg/mL Injection, Veterinary
Vol. 9 No. 3 228 Meloxicam 0.2 mg/mL Oral Liquid, Veterinary
Vol. 9 No. 3 229 Methimazole 10-mg/mL Oral Liquid, Veterinary
Vol. 9 No. 3 230 Metronidazole 1% and Silver Sulfadiazine 1% Cream, Veterinary
Vol. 9 No. 3 231 Pergolide 500-mcg Capsules, Veterinary
Vol. 9 No. 3 232 Pergolide 0.2-mg/mL Oral Liquid, Veterinary
Vol. 9 No. 3 233 Phenoxybenzamine Hydrochloride 5-mg Capsules, Veterinary
Vol. 9 No. 3 234 Piroxicam 2-mg/mL Oral Liquid, Veterinary
Vol. 9 No. 3 235 Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration
Vol. 9 No. 3 238 Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration
Vol. 9 No. 3 242 Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study
Vol. 9 No. 3 247 PostScription: AVMA's Position on Compounding for Animals
Vol. 9 No. 4 250 Prescription: Support Your Local College of Pharmacy
Vol. 9 No. 4 252 Book Reviews: Awakening Athena: Resilience, Restoration, and Rejuvenation for Women
Vol. 9 No. 4 253 Book Reviews: Perfect Balance
Vol. 9 No. 4 254 Literature Reviews
Vol. 9 No. 4 259 Testosterone Replacement Therapy for Female Androgen Insufficiency Syndrome
Vol. 9 No. 4 266 Guidelines for Consulting with Patients about Bioidentical Hormone Replacement Therapy
Vol. 9 No. 4 268 Hypothyroidism: Optimizing Therapy with Slow-Release Compounded Thyroid Replacement
Vol. 9 No. 4 275 Compounding for Endocrine Disorders in Adult Patients
Vol. 9 No. 4 281 Natural Progesterone Handout
Vol. 9 No. 4 284 Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products
Vol. 9 No. 4 293 Local Ventilation for Safe Containment in the Pharmaceutical Industry
Vol. 9 No. 4 300 Quality-Control Analytical Methods: Glossary of Quality Control/Quality Assurance Terms in Pharmaceutical Compounding
Vol. 9 No. 4 303 Basics of Pharmacogenomics for the Compounding Pharmacist
Vol. 9 No. 4 307 Calculations
Vol. 9 No. 4 309 Standard Operating Procedure: Employee Personnel Records
Vol. 9 No. 4 310 BMS Mouthwash
Vol. 9 No. 4 311 Bonain's Solution
Vol. 9 No. 4 312 Brompton's Mixture
Vol. 9 No. 4 313 Bunnel's Solutions
Vol. 9 No. 4 314 Burow's Solution
Vol. 9 No. 4 315 Joulie's Solution
Vol. 9 No. 4 316 Shohl's Solution, Modified (Albright's Solution)
Vol. 9 No. 4 317 Suby-Albright Solution "G" Irrigation
Vol. 9 No. 4 318 Suby-Albright Solution "M" Irrigation
Vol. 9 No. 4 319 Whitehead's Varnish
Vol. 9 No. 4 320 Physical and Chemical Stability of Palonosetron Hydrochloride with Fluorouracil and with Gemcitabine Hydrochloride during Simulated Y-site Administration
Vol. 9 No. 4 323 Stability of Nebulizer Admixtures
Vol. 9 No. 4 327 PostScription: Women in Balance: A Cause Worth Advancing
Vol. 9 No. 5 330 Prescription: Pharmacy Compounding Worldwide
Vol. 9 No. 5 332 Book Reviews: Lawsuit Lottery: The Hijacking of Justice in America
Vol. 9 No. 5 333 Literature Reviews
Vol. 9 No. 5 339 Dextromethorphan, an NMDA receptor antagonist, as a Treatment for Pain
Vol. 9 No. 5 349 Prescription for Relief: One Woman's Experience with Intractable Nonmalignant Pain
Vol. 9 No. 5 354 A Patient's Guide to Transdermal Treatment of Pain
Vol. 9 No. 5 357 Formulating for the Gluten-sensitive Individual
Vol. 9 No. 5 361 Basics of Compounding: Using Chemical Conversion Factors
Vol. 9 No. 5 364 Compounding: A Well-established Practice in 1938
Vol. 9 No. 5 369 Technology Update: An Overview of PDA-based Software Applications for Practicing Pharmacists
Vol. 9 No. 5 380 Back to the Basics of Business
Vol. 9 No. 5 382 Standard Operating Procedure: Denver Instrument Company M-120 Analytical Balance--Calibration, Cleaning, and Use
Vol. 9 No. 5 384 Calculations
Vol. 9 No. 5 386 Acetaminophen 400-mg, Aspirin 250-mg, Codeine Phosphate 30-mg with Antacids Capsules
Vol. 9 No. 5 387 Acetaminophen 325-mg, Codeine Phosphate 32.5-mg, and Phenyltoloxamine Citrate 30-mg Capsules
Vol. 9 No. 5 388 Aspirin 380-mg, Caffeine 30-mg, and Codeine Phosphate 30-mg Capsules
Vol. 9 No. 5 389 Aspirin 325-mg, Codeine Phosphate 30-mg, Aluminum Glycinate 48.6-mg, and Magnesium Carbonate 97.2-mg Capsules
Vol. 9 No. 5 390 Meperidine Hydrochloride 50-mg and Atropine Sulfate 0.4-mg/mL Injection
Vol. 9 No. 5 391 Meperidine Hydrochloride 50-mg and Promethazine Hydrochloride 12.5-mg Capsules
Vol. 9 No. 5 392 Meperidine Hydrochloride 50-mg and Promethazine Hydrochloride 25-mg Capsules
Vol. 9 No. 5 393 Methadone Hydrochloride 0.33-mg/mL Oral Solution
Vol. 9 No. 5 394 Morphine Sulfate 16-mg and Atropine Sulfate 0.4-mg/mL Injection
Vol. 9 No. 5 395 Morphine Sulfate 5-mg/mL PCA Injection (Concentration May Vary)
Vol. 9 No. 5 396 Stability and Subjective Taste Acceptability of Four Glycopyrrolate Solutions for Oral Administration
Vol. 9 No. 5 399 Chemical Stability of Hydralazine Hydrochloride after Reconstruction in 0.9% Sodium Chloride Injection or 5% Dextrose Injection for Infusion
Vol. 9 No. 5 402 Stability of Sotalol Hydrochloride in Extemporaneously Prepared Oral Suspension Formulations
Vol. 9 No. 5 407 PostScription: Searching for Barrier Isolator Information?
Vol. 9 No. 6 410 Prescription: Pediatric Formulation Initiatives
Vol. 9 No. 6 413 Unlocking Autism: Is Compounding the Key?
Vol. 9 No. 6 423 Compounding for a Pediatric Hospital
Vol. 9 No. 6 433 Wiping Out Diaper Rash
Vol. 9 No. 6 437 Pediatric Oral Liquid Preparations
Vol. 9 No. 6 445 Marketing Your Business for Success
Vol. 9 No. 6 449 Compounding Around the World: Portugal
Vol. 9 No. 6 452 Profile: The McGuff Companies. Part 1: Compounding and Manufacturing Share Facilities and Build Corporate Success
Vol. 9 No. 6 456 Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions
Vol. 9 No. 6 462 Quality Control Analytical Methods: Quality Issues Related to Compounding with Commercial Products
Vol. 9 No. 6 470 Standard Operating Procedure: Washing Glassware and Equipment Used in Compounding Nonsterile Preparations
Vol. 9 No. 6 471 Calculations
Vol. 9 No. 6 472 Alprazolam 1-mg/mL Oral Liquid
Vol. 9 No. 6 473 Bethanechol 5-mg/mL Oral Liquid
Vol. 9 No. 6 474 Clonazepam 0.1-mg/mL Oral Liquid
Vol. 9 No. 6 475 Dolasetron 10-mg/mL Oral Liquid
Vol. 9 No. 6 476 Ganciclovir 100-mg/mL Oral Liquid
Vol. 9 No. 6 477 Isradipine 1-mg/mL Oral Liquid
Vol. 9 No. 6 478 Pyrazinamide 10-mg/mL Oral Liquid
Vol. 9 No. 6 479 Quinidine Sulfate 10-mg/mL Oral Liquid
Vol. 9 No. 6 480 Ursodiol 25-mg/mL Oral Liquid
Vol. 9 No. 6 481 Valganciclovir Hydrochloride 60-mg/mL Oral Liquid
Vol. 9 No. 6 482 Chemical Stability of Fentanyl in Polypropylene Syringes and Polyvinylchloride Bags
Vol. 9 No. 6 484 Chemical Stability of Perphenazine in Oral Liquid Dosage Forms
Vol. 9 No. 6 487 PostScription: Compounding Pharmacies and the Successful Treatment of Autism